Cystic Fibrosis News Today
Skip to content
  • Home
  • Social Clips
  • CF Overview
    • Cystic Fibrosis Overview
    • Cystic Fibrosis Symptoms
    • Cystic Fibrosis Diagnosis
    • Cystic Fibrosis Prognosis & Therapies
    • Cystic Fibrosis and Sexuality
    • Cystic Fibrosis-related Diabetes (CFRD)
    • Osteoporosis and Osteopenia in Cystic Fibrosis
  • News Categories
    • CF Foundation
    • Pseudomonas Aeruginosa
    • Kalydeco
    • FDA
    • Fundraising
    • Orkambi
  • Information
    • Cystic Fibrosis Causes
    • Cystic Fibrosis Medications
      • Kalydeco
      • Orkambi
      • Antibiotics
        • Amikin (amikacin)
        • Aminoglycosides
        • Azithromycin
        • Aztreonam
        • Gentamicin
        • Cephalosporins
        • Linezolid (Zyvox)
        • Macrolides
        • Penicillin
        • Quinolones
        • Sulfonamides
        • Tetracyclines
        • Tobramycin
      • Mucolytics
        • Bronchodilators for CF – Albuterol (Ventolin, Proventil)
        • Bronchodilators for CF – Levalbuterol Hydrochloride (Xopenex)
        • Hypertonic Saline
        • Dornase Alfa
        • Pulmozyme (Dornase Alfa)
      • Enzymes
        • Pancreatin/Pancrelipase
        • PERT
        • Probiotics and Prebiotics for Cystic Fibrosis
      • Experimental Therapies
        • Lumacaftor (VX-809)
      • Cystic Fibrosis and Vitamins
        • AquADEKs for Nutritional-GI in CF
    • Cystic Fibrosis in Children
    • Cystic Fibrosis Life Expectancy
    • Cystic Fibrosis and Exercise
    • Cystic Fibrosis Genetics
    • Cystic Fibrosis and Nutrition
    • Cystic Fibrosis Research
    • Cystic Fibrosis and Emotional Wellness
    • Living with Cystic Fibrosis
    • Cystic Fibrosis Foundation
    • Pseudomonas aeruginosa
    • Caring for a Family Member with Cystic Fibrosis
    • Clinical Trials
      • About Clinical Trials
      • Clinical Trial Notification Program
  • CF Therapy Tracker
    • Acebilustat (Formerly CTX-4430)
    • Aerovanc (Vancomycin Inhalation Powder)
    • Ataluren
    • AZD5634
    • Cavosonstat (N91115)
    • CRISPR/Cas9
    • CTP-656
    • FDL169
    • Fosfomycin/Tobramycin
    • Gallium
    • Glutathione
    • Inhalable Ibuprofen
    • Inhaled Levofloxacin (Quinsair)
    • Inhaled Liposomal Amikacin
    • GS-5745
    • LAU-7b
    • Liprotamase
    • OligoG
    • Nitric Oxide (Inhaled)
    • POL6014
    • PTI-428
    • QBW251
    • QR-010
    • Resunab (formerly JBT-101)
    • Riociguat
    • SPX-101
    • Tezacaftor (VX-661)
    • Theradux (formerly OrPro and ORP-100)
    • VX-152
    • VX-371 (Formerly P-1037)
    • VX-440
    • VX-659
  • Resources
    • The Pfizer Therapeutic Program for Cystic Fibrosis
    • The Sanofi Genzyme Therapeutic Program for Cystic Fibrosis
    • The Southern Research Therapeutic Program for Cystic Fibrosis
  • Columns
    • The Patient’s Perspective
    • CF Regenerative Medicine
    • Victorious
    • An Undeniable Hope
    • Life In the Grey

Profile

April 8, 2014July 4, 2016
adminby admin

Home » Profile

[symposium-profile]

Get Our Free CF Email Newsletter

* indicates required

Recent CF Posts

  • Phase 2b anabasum trial

    Corbus Plans to Start Phase 2b Trial of Its Cystic Fibrosis Therapy Anabasum by Year’s End

    August 17, 2017

  • Digestion therapy trial design

    European Experts OK Design of Trial to Assess Sollpura for CF-related Digestive Disorder

    August 16, 2017

  • Claire Wineland Shows That It’s Possible to Live a Full Life With Cystic Fibrosis

    August 16, 2017

  • tube feeding formula

    Kate Farms Launches Core Essentials Peptide Tube Feeding Formula for CF, Other Conditions

    August 15, 2017

  • parents

    A Letter to CF Parents

    August 15, 2017

You May Also Like…

40 Cystic Fibrosis Patients or Family Members Win Vertex’s First All in for CF Scholarships

May 23, 2017

Vertex scholarship winners

A Look Back at the Milestones in the Study of the Respiratory System

July 11, 2017

More Reader Tattoos That Have Inspired Us

July 17, 2017

Visit Cystic Fibrosis News Today's profile on Pinterest.

CF News Today

BioNews Services, LLC
5307 E. Mockingbird Ln.
5th Floor
Dallas, TX 75206
Email: info@cysticfibrosisnewstoday.com
Phone: 1-800-936-1363

BioNews Feed

Recent Posts

  • Phase 2b anabasum trial

    Corbus Plans to Start Phase 2b Trial of Its Cystic Fibrosis Therapy Anabasum by Year’s End

    August 17, 2017

  • Digestion therapy trial design

    European Experts OK Design of Trial to Assess Sollpura for CF-related Digestive Disorder

    August 16, 2017

  • Claire Wineland Shows That It’s Possible to Live a Full Life With Cystic Fibrosis

    August 16, 2017

  • tube feeding formula

    Kate Farms Launches Core Essentials Peptide Tube Feeding Formula for CF, Other Conditions

    August 15, 2017

  • About CF News Today
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Advertising

Disclaimer:

Cystic Fibrosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
Copyright © 2013-2017 All rights reserved.